Director, Integrated Development Services, Early Development
Quotient Sciences
Nottingham, England, United Kingdom
Dr. Dolly Jacob works as Director, Integrated Development Services, Early Development within Quotient Sciences. Dolly has over 18 years’ experience in the Pharma industry in management and technical roles with a focus on early drug development strategies and implementation. Dolly has been with Quotient Sciences since 2015, she has led formulation development teams and supported operational delivery of Translational Pharmaceutics programs globally.
Dolly has previously worked for 3M Healthcare, Astra Zeneca and Cipla Ltd. developing formulation and products for various dosage forms and drug delivery systems. Dolly completed PhD research study investigating the performance and reliability of an implantable closed loop insulin delivery device (INsmart Artificial Pancreas) from De Montfort University, Leicester in 2015 and has Pharmacy degree and masters from University of Pune, India and SNDT University Mumbai. Dolly has co-authored papers in the areas of modified release formulation development, drug delivery device, drug delivery kinetics, and device material compatibility.
A Formulators Guide to Crossing the Valley of Death
Tuesday, October 24, 2023
3:30 PM – 4:30 PM ET